Lv4
560 积分 2024-11-18 加入
On the Robustness of LISREL (Maximum Likelihood Estimation) Against Small Sample Size and Non-normality
13天前
已完结
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study
1个月前
已完结
Biosimilar Cost Savings in the United States: Initial Experience and Future Potential
4个月前
已完结
The Crohnʼs and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access
4个月前
已完结
The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study
4个月前
已完结
Financial Toxicity in Crohn’s Disease
4个月前
已完结
A Narrative Review of Financial Burden, Distress, and Toxicity of Inflammatory Bowel Diseases in the United States
4个月前
已完结
XAFS for Everyone （2nd Edition）
4个月前
已驳回
XAFS for Everyone （2nd Edition）
4个月前
已撤回
皖公网安备34019202002308
